These MNC pharma companies launching new products using unlisted entities maybe discussed and beaten to death. That’s a risk nevertheless.
” Companies with MNC parentage trade at a substantial premium to their domestic counterparts. Most of these companies have been listed for many decades and have created huge wealth for the shareholders. But many MNCs operate in India through multiple entities which deprive the listed entity of full range of products and growth opportunities. The risk of that is now becoming increasingly apparent with increasing instances of new products being launched in the unlisted entities – bringing the underlying risks to the fore.
Author: N Balaji Vaidyanath – Crest Wealth Management
(Views are personal and not that of the company)“
Source:
https://www.equitybulls.com/category.php?id=266382
| Subscribe To Our Free Newsletter |
